Trademark Overview
On Thursday, November 13, 2025, a trademark application was filed for ZENBEKEBI with the United States Patent and Trademark Office. The USPTO has given the ZENBEKEBI trademark a serial number of 99495143. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 17, 2026. This trademark is owned by Celgene Corporation. The ZENBEKEBI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer;; Pharmaceutical preparations for the treatment and prevention of Anticoagulants;; Pharmaceutical preparations for the treatment and prevention of Stem cells for medical purposes;; Pharmaceutical preparations for the treatment and prevention of Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Pharmaceutical preparations for the treatment and prevention of Diagnostic radiopharmaceutical preparations;; Pharmaceutical preparations for...
